Switch View
© PR Newswire
30.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Sept. 30, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX).
IF YOU ARE AN...
Themefolio
Profiler
Peergroup
© ActuNews
30.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Publishes First Half 2025 Results
News Preview
Leuven, BELGIUM – September 30, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, published today its financial and business update for the six-month period ending June 30, 2025.
The half-year report is available in the ‘Investors' section of the Company's webs...
Themefolio
Profiler
Peergroup
© ActuNews
30.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion publie ses résultats du premier semestre 2025
News Preview
Louvain, BELGIQUE – 30 Septembre, 2025 – 18:00 CET - Oxurion NV (Euronext Brussels: OXUR), entreprise biopharmaceutique basée à Louvain, a publié aujourd'hui ses résultats financiers et opérationnels pour le semestre clos le 30 Juin 2025.
Le rapport semestriel est disponible dans la section ‘...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© ActuNews
30.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion maakt halfjaarresultaten 2025 bekend
News Preview
Leuven, BELGIË – 30 September 2025 – 18:00 CET Oxurion NV (Euronext Brussel: OXUR) (de Vennootschap), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, maakt vandaag haar financiële en zakelijke update bekend voor het half jaar dat eindigde op 30 juni 2025.
Het halfjaarverslag is beschikbaar in de rubriek ‘Investe...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
30.09.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
Full renewal of the Board of Directors Election of Dr. Markus Cappel as Chairman of the Board of Directors
News Preview
Full renewal of the Board of DirectorsElection of Dr. Markus Cappel as Chairman of the Board of Directors...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
Altimmune, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ALT
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Altimmune, Inc. (“Altimmune” or “the Company”) (NASDAQ: ALT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of ALT during the cla...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: FR0010557264
AB Science SA
AB
LISTED
EURONEXT
AB Science announces a slight delay in the publication of its 2025 half-year financial report
News Preview
PRESS RELEASE...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2025
News Preview
Attachment...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
BetterInvesting™ Magazine Update on Vertiv Holdings Co. (NYSE: VRT) and CVS Health Corp. (NYSE: CVS)
News Preview
TROY, Mich., Sept. 30, 2025 /PRNewswire/ -- Vertiv Holdings Co.'s recent report has investors wondering if the company's stock is fairly valued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine consider Vertiv Holdings Co. (NYSE: VRT) as worthy...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: US4618741098
eXoZymes Inc
EXOZ
LISTED
NASDAQ
Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees
News Preview
LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 30, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced that two of its senior leaders - CCO Damien Perriman and VP of Development,...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: FR0012882389
Equasens
EQS
LISTED
EURONEXT
EQUASENS : Mise à disposition du rapport financier semestriel 2025
News Preview
Villers-lès-Nancy, le 30 septembre 2025 - 18h00 (CET)...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: FR0014008VX5
Euroapi S.A.
EAPI
LISTED
EURONEXT
Change in Board’s Composition
News Preview
Paris – September 30, 2025 - EUROAPI today announces that, in line with best governance’s practices, and following his appointment as Recipharm’s Chief Financial Officer, effective October 1st, 2025, Rodolfo J. Savitzky will step down from his role as EUROAPI’s Independent Director and Chair of the Audit Committee, effective December 31, 2025....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
30.09.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30
News Preview
SALT LAKE CITY, Sept. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be participating in a webcast presentation and hosting one...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US14149Y1082
Cardinal Health Inc
CAH
LISTED
NYSE
Cardinal Health to expand pharmaceutical distribution network with new Indianapolis facility
News Preview
DUBLIN, Ohio, Sept. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced plans for a new flagship forward distribution center in Indianapolis, Indiana that will further expand and modernize its national pharmaceutical distribution network. The state-of-the-art forward distribution center will feat...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Total number of shares and voting rights in Zealand Pharma as of September 30, 2025
News Preview
Company announcement – No. 21 / 2025...
Themefolio
Profiler
Peergroup
© Newsfile
30.09.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group Closes Earn-Out Agreement of Via Cibo Restaurant Chain
News Preview
Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce the closing of the earn-out agreement regarding the acquisition of the Via Cibo Restaurant Chain ("Via Cibo"). Via Cibo deliv...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US6700021040
Novavax Inc
NVAX
LISTED
NASDAQ
Novavax Announces Progress on Sanofi Agreement
News Preview
GAITHERSBURG, Md., Sept. 30, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced progress on its collaboration and license agreement (CLA) with Sanofi regarding Novavax's Matrix-M® adjuvant. The companies have amended their CLA to expand Sanofi's license to include use of Novavax's Matrix-M adjuvant...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
CVS Health to hold third quarter 2025 earnings conference call
News Preview
WOONSOCKET, R.I., Sept. 30, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, October 29th, 2025, at 8:00 a.m. ET to discuss third quarter 2025 financial results....
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US88033G4073
Tenet Healthcare Corp
THC
LISTED
NYSE
Tenet to Report Its Third Quarter 2025 Results on October 28th
News Preview
Tenet Healthcare Corporation (NYSE: THC) will release its third quarter 2025 results before the market opens on Tuesday, October 28, 2025, to be followed by a conference call at 9:30 a.m. CT (10:30 a.m. Eastern Time).
A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.ten...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the manufacturer of the Implantable Collamer® Lens (ICL), today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR), in connection with...
Themefolio
Profiler
Peergroup
© Newsfile
30.09.2025
ISIN: CA75671E1097
Red Light Holland Corp.
TRIP
LISTED
CSE
Red Light Holland Receives Official Psilocybin COA Through FDA-Compliant, DEA-Registered Partner, Irvine Labs, USA
News Preview
Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truff...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US52635N1037
LENZ Therapeutics Inc
LENZ
LISTED
NASDAQ
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
News Preview
VIZZ sample distribution initiated nationwide to Eye Care Professionals
Commercial product shipments to be initiated in October to consumers with broad product availability by mid-Q4 2025
VIZZ is the first and...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US04351N1063
Ascend Wellness Holdings, Inc
AAWH.U
LISTED
CSE
AWH Closes $9.3 Million Mortgage Financing on Three Ohio Properties
News Preview
NEW YORK, Sept. 30, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH" or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a leading multi-state, vertically integrated cannabis operator, entered into and closed, effective September 12, 2025, a $9,345,000 secured financing transaction with CF Bank, pursuant to w...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US00846U1016
Agilent Technologies Inc
A
LISTED
NYSE
Agilent Announces New Insight Series Alarm Resolution Systems for Airport Security Screening
News Preview
Agilent Technologies Inc. (NYSE: A) today announced the launch of its new Insight Series Alarm Resolution Systems, designed to enhance safety and streamline operations at airport security checkpoints worldwide. The Insight Series includes the Insight300M and InsightBLS, advanced liquid explosive detection systems (LEDs) that meet global regulation...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Natera Announces Publication of Signatera™ Validation Study in Testicular Cancer
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of a peer-reviewed manuscript in the Journal of Clinical Oncology - Precision Oncology (JCO PO). The paper features results from a multi-institutional study evaluating circulating tumor DNA (ctDNA) as a prognostic biomarker for pat...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the appointment of Lisa Gurry as Chief Business Officer (CBO), effective immediately. In this newly-created role, Gurry will lead GeneDx’s next phase of transformation, advancing data and information services across biopharma, health sys...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US91864C1071
Vaccitech plc
VACC
LISTED
NASDAQ
Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
News Preview
GERMANTOWN, MD and ALTRINCHAM, UK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- GERMANTOWN, MD and ALTRINCHAM, UK — September 30, 2025 — Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio”), an immunology and inflammation company focused on developing therapies that promote immune tolerance, and Clywedog Therapeutics, Inc. (“Clywedog”), a privat...
Themefolio
Profiler
Peergroup
© Newsfile
30.09.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
OS Therapies Provides OST-HER2 UK MHRA and US FDA Osteosarcoma Regulatory Update
News Preview
Company updates sequence of OST-HER2 regulatory submissions, prioritizing UK MHRA conditional Marketing Authorisation Application (MAA) submission following positive August 2025 Scientific Advice Meeting feedback from UK MHRAIn principle, UK MHRA accepts use of historical control arm to support conditional MAAUK MHRA conditional MAA and US FDA Biol...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US0043971052
Accuray Inc
ARAY
LISTED
NASDAQ
Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care
News Preview
MADISON, Wis., Sept. 30, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced today the signing of a memorandum of understanding (MOU) to advance online adaptive radiotherapy (OART) on the Accuray helical radiation treatm...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US67080N1019
Nuvation Bio Inc
NUVB
LISTED
NYSE
Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI™ (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer
News Preview
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced it has enrolled the first patient in TRUST-IV (NCT07154706), a Phase 3 study evaluating the efficacy and safety of IBTROZI™ (taletrectinib), a next-generation ROS1 inhibitor, versus placebo for the adju...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US74019P1084
Precision BioSciences Inc
DTIL
LISTED
NASDAQ
Precision BioSciences Announces Late-Breaking Poster Presentation at the 30th Annual International Congress of the World Muscle Society
News Preview
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced a late-breaking poster presentation at the 30th Annual International Congress of the World Muscle Society (WMS) being held October...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US5049221055
Labcorp Holdings Inc
LH
LISTED
NYSE
Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities
News Preview
Labcorp to leverage Roche's digital pathology technology to expand access, enhance efficiency and support AI integration across anatomic pathology services
BURLINGTON, N.C., Sept. 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and com...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: CH1384053976
NLS Pharmaceutics AG
NLSP
LISTED
NASDAQ
NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting
News Preview
Vote clears final corporate milestone, paving the way for the closing of the merger and the combined company of NewCelX Ltd., a Nasdaq-listed biotechnology company
ZURICH, Sept. 30, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: KYG1281K1067
Silexion Therapeutics Corp
SLXN
LISTED
NASDAQ
Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-KRAS Activity of SIL204, Demonstrating Up to 99.7% Inhibition and First Evidence in Gastric Cancer
News Preview
New data in human cancer cell lines provides confirmation of pan-KRAS mutation inhibition with inhibition of G12D, G12V, G12R, G12C, G13C, G12A, Q61H, and G13D mutations...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: DK0060448595
Coloplast A/S
COLO B
LISTED
CPH
Coloplast A/S - Financial Calendar 2025-26
News Preview
Please see enclosed pdf....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US8902604094
Tonix Pharmaceuticals Holding Corp.
TNXP
LISTED
NASDAQ
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market Access
News Preview
Mr. Kamath brings more than 25 years of market access, pricing, and commercial operations experience to Tonix...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US2546041011
Disc Medicine Inc
IRON
LISTED
NASDAQ
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
News Preview
WATERTOWN, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the submission of a New Drug Application (NDA) to the U.S. Foo...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US92859E1082
Vivos Therapeutics Inc.
VVOS
LISTED
NASDAQ
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device
News Preview
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US82711P2011
Silo Pharma, Inc.
SILO
LISTED
NASDAQ
Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
News Preview
SARASOTA, FL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced that it has entered into definitive agreements for...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: JP3546800008
Terumo Corporation
45430
LISTED
XJPX
Kenya, Uganda and Côte d'Ivoire Partner with Terumo Blood and Cell Technologies to Build Coordinated National Care Frameworks for Sickle Cell Care
News Preview
LAKEWOOD, Colo., Sept. 30, 2025 /PRNewswire/ -- In a landmark move, the Ministries of Health of Kenya and Côte d'Ivoire, together with Uganda's Joint Clinical Research Centre (JCRC) under the stewardship of the Uganda Ministry of Health, have signed three Memoranda of Understanding (MoUs) with Terumo Blood and Ce...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US91864C1071
Vaccitech plc
VACC
LISTED
NASDAQ
Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
News Preview
GERMANTOWN, Md. and ALTRINCHAM, United Kingdom, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio”), an immunology and inflammation company focused on developing therapies that promote immune tolerance, and Clywedog Therapeutics, Inc. (“Clywedog”), a private company advancing novel breakthrough medici...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk
News Preview
Ozempic® is now available at this reduced price to eligible self-pay LifeMD patients Ozempic® is now available at this reduced price to eligible self-pay LifeMD patients...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US52635N1037
LENZ Therapeutics Inc
LENZ
LISTED
NASDAQ
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
News Preview
VIZZ sample distribution initiated nationwide to Eye Care Professionals...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US7743743004
Rockwell Medical Inc
RMTI
LISTED
NASDAQ
Rockwell Medical Promotes Heather Hunter to Chief Operating Officer
News Preview
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Heather Hunter was promoted to Chief Operating Officer, and will continue to report to the Company's President and CEO, D...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.09.2025
ISIN: DE000A3MQR65
Viromed Medical AG
Q11
LISTED
XETRA
Viromed Medical AG startet In-vivo- und Ex-vivo-Studie mit Kaltplasma an lebenden Lungen
News Preview
PRESSEMITTEILUNG
Viromed Medical AG startet In-vivo- und Ex-vivo-Studie mit Kaltplasma an lebenden Lungen
Rellingen, 30. September 2025 – Die Viromed Medical AG („Viromed“; ISIN: DE000A3MQR65), ein Medizintechnikunternehmen und Pionier der Kaltplasmatechnologie, gibt den Start einer umfangreichen In-vivo- und Ex-vivo-Studie an lebenden Lungen bek......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.09.2025
ISIN: DE000A3MQR65
Viromed Medical AG
Q11
LISTED
XETRA
Viromed Medical AG launches in vivo and ex vivo study with cold plasma on living lungs
News Preview
PRESS RELEASE
Viromed Medical AG launches in vivo and ex vivo study with cold plasma on living lungs
Rellingen, September 30, 2025 – Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology, announces the start of a comprehensive in vivo and ex vivo study on living lungs. The in vivo a......
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US74754R1032
Qualigen Therapeutics, Inc.
QLGN
LISTED
NASDAQ
Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto
News Preview
Carlsbad, CA, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or “the Company”) today announced the successful closing of a $41 million private investment in public equity (PIPE) financing led by Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“FF”), along with its Founder and Global Co-CEO YT Ji...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US67576A1007
Ocular Therapeutix Inc
OCUL
LISTED
NASDAQ
Ocular Therapeutix™ Announces Pricing of Underwritten Offering of Common Stock
News Preview
BEDFORD, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (Nasdaq: OCUL) (“Ocular”, the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced the pricing of an underwritten offering of 37,909,018 shares of its common stock at an offering price of $12.53 per share for g...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US00461U1051
Aclaris Therapeutics Inc
ACRS
LISTED
NASDAQ
Aclaris Therapeutics to Host In-Person and Webcast R&D Day, “Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets”, in New York on October 14, 2025
News Preview
Aclaris Therapeutics to Host In-Person and Webcast R&D Day in New York on October 14, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: CA39342L1085
Green Thumb Industries Inc
GTII
LISTED
CSE
Green Thumb Expands Pennsylvania Retail Footprint with RISE Dispensary Lebanon
News Preview
CHICAGO and VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- RISE Dispensaries, a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced its latest Pennsylvania location, RISE Dispensary Lebanon. Located at 1600 W Cumberland St. conveni...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: NL0015000AG6
LAVA Therapeutics N.V.
LVTX
LISTED
NASDAQ
LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025
News Preview
Additional time enables LAVA Therapeutics to address potential liabilities and confirm net cash to be delivered to Shareholders. LAVA Therapeutics and XOMA Royalty anticipate closing the announced acquisition in the fourth quarter of 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings
News Preview
NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare today anno...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US67577R1023
Opus Genetics, Inc.
IRD
LISTED
NASDAQ
Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)
News Preview
Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.09.2025
ISIN: AU000000CUV3
Clinuvel Pharmaceuticals Ltd
CUV
LISTED
ASX
Parmantier & Cie. GmbH: CLINUVEL Pharmaceuticals Limited | Rating: Buy
News Preview
Original-Research: CLINUVEL Pharmaceuticals Limited - from Parmantier & Cie. GmbH
30.09.2025 / 10:52 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to c......
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
Orion’s phase 2 study of ODM-105 in insomnia did not meet primary goal
News Preview
ORION CORPORATION PRESS RELEASE 30 SEPTEMBER 2025 at 13.00 EEST ...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
WINREVAIR™ (sotatercept-csrk) Reduced the Risk of Clinical Worsening Events by 76% Compared to Placebo in Patients Recently Diagnosed With PAH on Background Therapy in Phase 3 HYPERION Trial
News Preview
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive results from the Phase 3 HYPERION trial evaluating WINREVAIR™ (sotatercept-csrk) versus placebo (both in combination with background therapy) in recently diagnosed adults with pulmonary arterial hypertension (PAH, WHO* Group 1) functional class (FC) II o...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: SE0007464888
Karo Pharma AB
KARO
LISTED
STO
Karo Healthcare appoints Konstanze Gallinatus as Chief Transformation Officer
News Preview
Karo Healthcare ("Karo") has appointed Konstanze Gallinatus as Chief Transformation Officer and member of the Corporate Management Team.
STOCKHOLM, Sept. 30, 2025 /PRNewswire/ -- The appointment of Konstanze reflects Karo's significant growth ambitions in the years ahead and the steps Karo is taki...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: US29350E1047
Enochian Biosciences, Inc
ENOB
LISTED
NASDAQ
Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense
News Preview
LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 30, 2025 / Lunai Bioworks Inc. (Nasdaq:LNAI), a pioneer in AI-powered drug discovery and biodefense, today announced the formal adoption of its new corporate identity, reflecting a sharpened strategic focus and a streamlined capital structure following a 10:1 reverse stock split.The rebranding f...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: US47010C4096
Jaguar Health, Inc.
JAGX
LISTED
NASDAQ
FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease
News Preview
The two programs are being conducted under separate Single-Patient Investigational New Drug (sIND) applications in the United States SAN FRANCISCO, CA / ACCESS Newswire / September 30, 2025 / Jaguar Health (NASDAQ:JAGX) today announced that Jaguar family company Napo Pharmaceuticals (Napo) is providing the company's novel crofelemer powder for oral...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
